BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 6368620)

  • 1. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
    Goldenhersh MA; Olsen TG
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant potential of keratoacanthoma.
    Butcher RB
    Laryngoscope; 1979 Jul; 89(7 Pt 1):1092-8. PubMed ID: 449552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are keratoacanthomas really squamous cell carcinomas?
    Sanders GH; Miller TA
    Ann Plast Surg; 1982 Oct; 9(4):306-9. PubMed ID: 7149561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratoacanthoma: is it a real entity?
    Manstein CH; Frauenhoffer CJ; Besden JE
    Ann Plast Surg; 1998 May; 40(5):469-72. PubMed ID: 9600429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of S100 protein-positive cells in inflamed and non-inflamed keratoacanthoma and squamous cell carcinoma.
    Korenberg R; Penneys NS; Kowalczyk A; Nadji M
    J Cutan Pathol; 1988 Apr; 15(2):104-8. PubMed ID: 3372786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas.
    Schnur PL; Bozzo P
    Plast Reconstr Surg; 1978 Aug; 62(2):258-62. PubMed ID: 674415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histopathologic differentiation of keratoacanthoma and squamous cell carcinoma of the skin.
    Kern WH; McCray MK
    J Cutan Pathol; 1980 Oct; 7(5):318-25. PubMed ID: 7430483
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
    Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
    Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it skin cancer--or keratoacanthoma?
    Greene SL; Perry HO
    Geriatrics; 1984 Sep; 39(9):91-4, 98-9, 102. PubMed ID: 6468938
    [No Abstract]   [Full Text] [Related]  

  • 14. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
    Fraga GR; Chow P
    J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
    King DF; Barr RJ
    J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
    Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
    Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic problem of keratoacanthoma.
    Jackson IT
    Lancet; 1969 Mar; 1(7593):490-2. PubMed ID: 4179571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.